CommercialCoverageMedium impact
Clinical Policy Update Provider Notification
Ambetter·NJ · Pulmonology, Urology, OB-GYN +1 more·Medical Policy
Effective date
Oct 2, 2026
We identified it
Aug 26, 2026
Summary
Ambetter is implementing revisions to three medical policies effective October 2, 2026: Pulmonary Function Testing (CP.MP.242), Testing for Select Genitourinary Conditions (CP.MP.97), and Scanning Computerized Ophthalmic Diagnostic Imaging (CP.VP.14). The policies clarify medical necessity criteria for these diagnostic procedures and specify which indications are not covered. Billing teams must review the revision log on Ambetter's website and update prior authorization and billing rules accordingly.
Action Required
By September 18, 2026: Billing team must access the full revision log on the Ambetter website (https://www.ambetterhealth.com/en/nj/provider-resources/provider-news/clinical-policy-update-provider-notification/) to identify specific changes to policies CP.MP.242 (Pulmonary Function Testing), CP.MP.97 (Genitourinary Testing), and CP.VP.14 (Ophthalmic Imaging). Update prior authorization rules, denial criteria, and billing system edits in the EHR/billing software to enforce the revised medical necessity guidelines. Notify providers in pulmonology, urology, gynecology, and ophthalmology of the changes. Update encounter documentation templates to ensure providers capture appropriate clinical indicators. Implement system edits to deny non-covered indications (e.g., screening for glaucoma under CP.VP.14, advanced glaucomatous damage). Failure to implement these changes by the effective date will result in incorrect claim submissions and potential denials.